|
1
|
Mindermann T and Wilson CB: Age-related
and gender-related occurrence of pituitary adenomas. Clin
Endocrinol (Oxf). 41:359–364. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dessimoz C, Browaeys P, Maeder P, et al:
Transformation of a microprolactinoma into a mixed growth hormone
and prolactin-secreting pituitary adenoma. Front Neuroendocrin
(Lausanne). 2:1162011.PubMed/NCBI
|
|
3
|
Daly AF, Rixhon M, Adam C, Dempegioti A,
Tichomirowa MA and Beckers A: High prevalence of pituitary
adenomas: a cross-sectional study in the province of Liege,
Belgium. J Clin Endocrinol Metab. 91:4769–4775. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma W, Ikeda H and Yoshimoto T:
Clinicopathologic study of 123 cases of prolactin-secreting
pituitary adenomas with special reference to multihormone
production and clonality of the adenomas. Cancer. 95:258–266. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ahtiainen P, Sharp V, Rulli SB, et al:
Enhanced LH action in transgenic female mice expressing
hCGbeta-subunit induces pituitary prolactinomas; the role of high
progesterone levels. Endocr Relat Cancer. 17:611–621. 2010.
View Article : Google Scholar
|
|
6
|
Ali S, Miller KK and Freudenreich O:
Management of psychosis associated with a prolactinoma: case report
and review of the literature. Psychosomatics. 51:370–376. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gillam MP, Molitch ME, Lombardi G and
Colao A: Advances in the treatment of prolactinomas. Endocr Rev.
27:485–534. 2006. View Article : Google Scholar
|
|
8
|
Vlotides G, Cooper O, Chen YH, Ren SG,
Greenman Y and Melmed S: Heregulin regulates prolactinoma gene
expression. Cancer Res. 69:4209–4216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leriche VK, Asa SL and Ezzat S: Epidermal
growth factor and its receptor (EGF-R) in human pituitary adenomas:
EGF-R correlates with tumor aggressiveness. J Clin Endocrinol
Metab. 81:656–662. 1996.PubMed/NCBI
|
|
10
|
Roncaroli F, Nosé V, Scheithauer BW, et
al: Gonadotropic pituitary carcinoma: HER-2/neu expression and gene
amplification. Report of two cases. J Neurosurg. 99:402–408. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Onguru O, Scheithauer BW, Kovacs K, et al:
Analysis of epidermal growth factor receptor and activated
epidermal growth factor receptor expression in pituitary adenomas
and carcinomas. Mod Pathol. 17:772–780. 2004. View Article : Google Scholar
|
|
12
|
Zhang H, Berezov A, Wang Q, et al: ErbB
receptors: from oncogenes to targeted cancer therapies. J Clin
Invest. 117:2051–2058. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tzahar E, Waterman H, Chen X, et al: A
hierarchical network of interreceptor interactions determines
signal transduction by Neu differentiation factor/neuregulin and
epidermal growth factor. Mol Cell Biol. 16:5276–5287. 1996.
|
|
14
|
Vlotides G, Siegel E, Donangelo I, Gutman
S, Ren SG and Melmed S: Rat prolactinoma cell growth regulation by
epidermal growth factor receptor ligands. Cancer Res. 68:6377–6386.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wierinckx A, Roche M, Raverot G, et al:
Integrated genomic profiling identifies loss of chromosome 11p
impacting transcriptomic activity in aggressive pituitary PRL
tumors. Brain Pathol. 21:533–543. 2011.PubMed/NCBI
|
|
16
|
Toedling J, Sklyar O, Huber W, et al:
Ringo - an R/Bioconductor package for analyzing ChIP-chip readouts.
BMC Bioinformatics. 8:2212007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
20
|
Kanehisa M: The KEGG database. Novartis
Found Symp. 247:91–103; discussion 119–128, 244–152. 2002.
View Article : Google Scholar
|
|
21
|
Hulsegge I, Kommadath A and Smits MA:
Globaltest and GOEAST: two different approaches for Gene Ontology
analysis. BMC Proc. 3(Suppl 4): S102009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Becker RA, Chambers JM and Wilks AR: The
New S Language: A Programming Environment for Data Analysis and
Graphics. 1. Chapman & Hall; London: 1988
|
|
23
|
Melmed S: Mechanisms for pituitary
tumorigenesis: the plastic pituitary. J Clin Invest. 112:1603–1618.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Casanueva FF, Molitch ME, Schlechte JA, et
al: Guidelines of the Pituitary Society for the diagnosis and
management of prolactinomas. Clin Endocrinol (Oxf). 65:265–273.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Olafsdottir A and Schlechte J: Management
of resistant prolactinomas. Nat Clin Pract Endocrinol Metab.
2:552–561. 2006. View Article : Google Scholar
|
|
26
|
Whitelaw BC, Dworakowska D, Thomas NW, et
al: Temozolomide in the management of dopamine agonist-resistant
prolactinomas. Clin Endocrinol (Oxf). 76:877–886. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ragel BT and Couldwell WT: Pituitary
carcinoma: a review of the literature. Neurosurg Focus. 16:E72004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Riva C, Leutner M, Capella C, et al:
Different expression of chromogranin A and chromogranin B in
various types of pituitary adenomas. Zentralbl Pathol. 139:165–170.
1993.PubMed/NCBI
|
|
29
|
Jin L, Scheithauer BW, Young WF Jr, Davis
DH, Klee GG and Lloyd RV: Pancreastatin secretion by pituitary
adenomas and regulation of chromogranin B mRNA expression. Am J
Pathol. 148:2057–2066. 1996.PubMed/NCBI
|
|
30
|
Louthan O: Chromogranin a in physiology
and oncology. Folia Biol (Praha). 57:173–181. 2011.PubMed/NCBI
|
|
31
|
Golomb L, Bublik DR, Wilder S, et al:
Importin 7 and exportin 1 link c-Myc and p53 to regulation of
ribosomal biogenesis. Mol Cell. 45:222–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Atasheva S, Fish A, Fornerod M and Frolova
EI: Venezuelan equine Encephalitis virus capsid protein forms a
tetrameric complex with CRM1 and importin alpha/beta that obstructs
nuclear pore complex function. J Virol. 84:4158–4171. 2010.
View Article : Google Scholar
|
|
33
|
Doege H, Bocianski A, Scheepers A, et al:
Characterization of human glucose transporter (GLUT) 11 (encoded by
SLC2A11), a novel sugar-transport facilitator specifically
expressed in heart and skeletal muscle. Biochem J. 359:443–449.
2001. View Article : Google Scholar
|
|
34
|
Kenzelmann D, Chiquet-Ehrismann R,
Leachman NT and Tucker RP: Teneurin-1 is expressed in
interconnected regions of the developing brain and is processed in
vivo. BMC Dev Biol. 8:302008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Beckmann J, Vitobello A, Ferralli J,
Kenzelmann Brož DK, Rijli FM and Chiquet-Ehrismann R: Human
teneurin-1 is a direct target of the homeobox transcription factor
EMX2 at a novel alternate promoter. BMC Dev Biol. 11:352011.
View Article : Google Scholar : PubMed/NCBI
|
